According to Zhitong Finance App News, Biotech (688177.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 162 million yuan, an increase of 4.3% over the previous year; net loss attributable to shareholders of listed companies of 119 million yuan; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of 123 million yuan; and a basic loss of 0.29 yuan per share.